Nabarun Dasgupta, MPH, Ph.D.

Scientific Advisor

Nabarun (Nab) Dasgupta is an epidemiologist who studies medication safety. He has depth of experience in controlled substances, including the use and nonmedical use of prescription opioid pain relievers and heroin. He has worked for diverse groups on reducing the adverse consequences of opioid use, including the WHO, non-profit organizations, CDC, FDA, local health departments, and the pharmaceutical industry.

He serves on the Scientific Advisory Board of the RADARSĀ® System, a non-profit nationwide surveillance system for prescription drug misuse, abuse and diversion. Nabarun helped create Project Lazarus, a successful prescription overdose prevention project in North Carolina.

Nabarun is the chief science officer and co-founder of a population health technology company, Epidemico, Inc. (now part of Booz Allen Hamilton), which builds bots that can read unstructured text and understand it in a medical context. Applied examples include social media monitoring for adverse events, situational awareness and early identification of infectious disease outbreaks, including mobile apps.

Nabarun earned his doctorate in epidemiology from the Gillings School of Global Public Health, University of North Carolina at Chapel Hill, focusing on pharmacoepidemiology. He completed his undergraduate at Princeton University in molecular biology and received a master of public health degree from Yale University in the epidemiology of microbial diseases.